Ovarian autoimmune disease: Clinical concepts and animal models

Cellular and Molecular Immunology

Volumn 11, Issue 6, 2014, Pages 510-521

  Warren, Bryce D ^a   Kinsey, William K ^a   McGinnis, Lynda K ^a   Christenson, Lane K ^a   Jasti, Susmita ^a   Stevens, Anne M ^b   Petroff, Brian K ^a,c   Petroff, Margaret G ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; TRANSCRIPTION FACTOR;

AIRE GENE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE MODEL; FEMALE INFERTILITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; IMMUNOLOGICAL TOLERANCE; NONHUMAN; OVARY INFLAMMATION; PATHOGENESIS; PREMATURE OVARIAN FAILURE; REVIEW; THYMIC MEDULLARY EPITHELIAL CELL; THYMUS; ADRENAL DISEASE; ANIMAL; COMPLICATION; FEMALE; IMMUNOLOGY; INFERTILITY, FEMALE; METABOLISM; MOUSE; OVARY DISEASE; REGULATORY T LYMPHOCYTE;

ADRENAL GLAND DISEASES; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFERTILITY, FEMALE; MICE; OVARIAN DISEASES; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS;

EID: 84908501676     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.97     Document Type: Review

References (107)

1. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 2012; 9: e1001356.
2. Forti G, Krausz C. Evaluation and treatment of the infertile couple. J Clin Endocrinol Metab 1998; 83: 4177-4188
3. Chandra A, Copen CE. Infertility and impaired fecundity in the United States, 1982-2010: data from the National Survey of Family Growth Natl Health Stat Rep 2013; 67: 1-19
4. Braxton J, Carey D, Davis D, Footman A, Flagg E, Grier L et al. Sexually Transmitted Disease Surveillance 2012. Atlanta, GA: Department of Health and Human Services: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 2013.
5. Brison DR, Roberts SA, Kimber SJ. How should we assess the safety of IVF technologies? Reprod Biomed Online 2013; 27: 710-721
6. Acosta AA, Anand Kumar TC, Andino N, Cooke ID, DeCherney AH, Qin-Sheng G et al. Recent Advances in Medically Assisted Conception. Geneva: World Health Organization, 1992.
7. Welt C. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol 2008; 68: 499-509
8. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 76: 604-606
9. van Kasteren Y, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999; 5: 483-492
10. Farhi J, Homburg R, Ferber A, Orvieto R, Ben Rafael Z. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure preempting the rise in basal follicle stimulating hormone levels. Hum Reprod 1997; 12: 241-243
11. Nikolaou D, Lavery S, Turner C, Margara R, Trew G. Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 2002; 17: 1106-1111
12. Valdez KE, Petroff BK. Potential roles of the aryl hydrocarbon receptor in female reproductive senescence. Reprod Biol 2004; 4: 243-258
13. Bagur AC, Mautalen CA. Risk of developing osteoporosis in untreated premature menopause. Calcif Tissue Int 1992; 51: 4-12
14. Kritz-Silverstein D, Barret-Connor E. Early menopause, number of reproductive years and bone mineral density in postmenopausal women. Am J Public Health 1993; 83: 983-991
15. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAmMedAssoc 2002; 288: 321-333
16. Silbergeld ED, Flaws JA. Chemicals and menopause: effects on age at menopause and on health status in the postmenopausal period. J Women's Health 1999; 8: 227-234
17. Kalantaridou SN, Braddock DT, Patronas NJ, Nelson LM. Treatment of autoimmune premature ovarian failure: case report. Hum Reprod 1999; 14: 1777-1782
18. Silva CA, Yamakami LY, Aikawa NE, Araujo DB, Carvalho JF, Bonfa E. Autoimmune primary ovarian insufficiency. Autoimmun Rev 2014; 13: 427-430
19. Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990; 9: 191-207
20. Sedmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol 1987; 6: 73-81
21. Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril 2005; 84: 958-965
22. Brandao Neto RA, de Carvalho JF. Diagnosis and classification of Addison's disease (autoimmune adrenalitis). Autoimmun Rev 2014; 13: 408-411
23. Anderson JR, Goudie RB, Gray KG, Timbury GC. Autoantibodies in Addison's disease. Lancet 1957; 1: 1123-1124
24. Winqvist O, Karlsson FA, Kämpe O 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339: 1559-1562
25. Chen S, Sawika J, Betterle C, Powell M, Prentice L, Volpato M et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996; 81: 1871-1876
26. Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 2002; 78: 270-279
27. Dal Pra C, Chen S, Furmaniak J, Smith B, Pedini B, Moscon A et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease. Eur J Endocrinol 2003; 148: 565-570
28. Arif S, Varela-Clvino R, Conway GS, Peakman M. 3b hydroxysteroid dehydrogenase autoantibodies in patients with idiopathic premature ovarian failure target N- and C-terminal epitopes. J Clin Endocrinol Metab 2001; 86: 5892-5897
29. Arif S, Vallian S, Farzaneh F, Zanone MM, James SL, Pietropaolo M et al. Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996; 81: 4439-4445
30. Lonsdale RN, Roberts PF, Trowell JE. Autoimmune oophoritis associated with polycystic ovaries. Histopathology 1991; 19: 77-81
31. Welt C, Falorni A, Taylor A, Martin K, Hall J. Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels. J Clin Endocrinol Metab 2005; 90: 3069-3076
32. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 107-134
33. Gloor E, Hurlimann J. Autoimmune oophoritis. Am J Clin Pathol 1984; 81: 105-109
34. La Marca A, Brozzetti A, Giovanna S, Stefania M, Annibale V, Alberto F. Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol 2010; 22: 277-282
35. Tsigkou A, Marzotti S, Borges L, Brozzetti A, Reis F, Candeloro P et al. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J Clin Endocrinol Metab 2008; 93: 1263-1269
36. Cowchock FS, McCabe JL, Montgomery BB. Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol 1988; 158: 118-119
37. Barbarino-Monnier P, Gobert B, Guillet-May F, Béné MC, Barbarino A, Foliguet B et al. Ovarian autoimmunity and corticotherapy in an in-vitro fertilization attempt. Hum Reprod 1995; 10: 2006-2007
38. Corenblum B, Rowe T, Taylor PJ. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 1993; 59: 988-991
39. Blumenfeld Z, Halachmi S, Peretz BA, Shmuel Z, Golan D, Makler A et al. Premature ovarian failure-the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 1993; 59: 750-755
40. Falorni A, Brozzetti A, Aglietti MC, Esposito R, Minarelli V, Tomaro ES et al. Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency. Clin Endocrinol 2012; 77: 453-458
41. Visser JA, Durlinger AL, Peters IJ, van den Heuvel ER, Rose UM, Kramer P et al. Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice. Endocrinology 2007; 148: 2301-2308
42. Falsetti L, Scalchi S, Villani MT, Bugari G. Premature ovarian failure. Gynecol Endocrinol 1999; 13: 189-195
43. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002; 23: 327-364
44. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004; 10: 163-175
45. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1997; 89: 777-779
46. Ryan MM, Jones HR. Myasthenia gravis and premature ovarian failure. Muscle Nerve 2004; 30: 231-233
47. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy J Clin Endocrinol Metab 2006; 91: 2843-2850
48. Betterle C, Greggio NA, Volpato M. Clinical Review 93: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1998; 83: 1049-1055
49. Wolff AS, Sarkadi AK, Maródi L, Kärner J, Orlova E, Oftedal BE et al. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. J Clin Immunol 2013; 33: 1341-1348
50. Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R et al. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2008; 93: 4389-4397
51. Ahonen P, Myllärniemi S, SipiläI, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients N Engl J Med 1990; 322: 1829-1836
52. Gylling M, Tuomi T, Bjorses P, Kontiainen S, Prartanen J, Christie MR et al. SS-cell autoantibodies, human leukocyte Antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy J Clin Endocrinol Metab 2000; 85: 4434-4440
53. HalonenM, Eskelin P,Myher AG, Perheentupa J,Husebye ES, Kampe O et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy phenotype J Clin Endocrinol Metab 2002; 87: 2568-2574
54. Perheentupa J. APS-1/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am 2002; 31: 295-320
55. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, HeinoM et al. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393-398
56. Aaltonen J, Bjorses P, Perheentupa J, Horelli-Kuitunen N, Palotie A, Peltonen L et al. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997; 17: 399-403
57. Heino M, Peterson P, Kudoh J, Shimizu N, Antonarakis SE, Scott HS et al. APECED mutations in the autoimmune regulator (AIRE) gene. Hum Mutat 2001; 18: 205-211
58. Mathis D, Benoist C. A decade of AIRE. Nat Rev Immunol 2007; 7: 645-650
59. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2: 1032-1039
60. Stockinger B. T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv Immunol 1999; 71: 229-265
61. Miller JFAP, Heath WR. Self-ignorance in the peripheral T-cell pool. Immunol Rev 1993; 133: 131-150
62. Jolicoeur C, Hanahan D, Smith KM. T-cell tolerance in transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci USA 1994; 91: 6707-6711
63. Anderson AC, Nicholson LB, Legge KL, Turchin V, Zaghouani H, Kuchroo VK. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J Exp Med 2000; 191: 761-770
64. Klein L, KlugmannM, Nave KA, Tuohy VK, Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med 2000; 6: 56-61
65. Klein L, Roettinger B, Kyewski B. Sampling of complementing selfantigen pools by thymic stromal cells maximizes the scope of central T cell tolerance. Eur J Immunol 2001; 31: 2476-2486
66. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298: 1395-1401
67. Derbinski J, Gabler J, Brors B, Tierling S, Jonnakuty S, Hergenhahn M et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Immunol 2005; 202: 33-45
68. Gotter J, Brors B, Hergenhahn M, Kyewski B. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J Exp Med 2004; 199: 155-166
69. Ramsey C, Winqvist O, Puhakka L, Halonen M, Moro A, Kampe O et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002; 11: 397-409
70. DeVoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med 2006; 203: 2727-2735
71. Fan Y, Rudert WA, Grupillo M, He J, Sisino G, Trucco M. Thymusspecific deletion of insulin induces autoimmune diabetes. EMBO J 2009; 28: 2812-2824
72. Gavanescu I, Kessler B, Ploegh H, Benoist C, Mathis D. Loss of Airedependent thymic expression of a peripheral tissue antigen renders it a target of autoimmunity. Proc Natl Acad Sci USA 2007; 104: 4583-4587
73. Kyewski B, Taubert R. How promiscuity promotes tolerance: the case of myasthenia gravis. Ann NY Acad Sci 2008; 1132: 157-162
74. Peterson P, Org T, Rebane A. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol 2008; 8: 948-957
75. Ramsey C, Bukrinsky A, Peltonen L. Systematic mutagenesis of the functional domains of AIRE reveals their role in intracellular targeting. Hum Mol Genet 2002; 11: 3299-3308
76. Kumar PG, Laloraya M, Wang CY, Ruan QG, Davoodi-Semiromi A, Kao KJ et al. The autoimmune regulator (AIRE) is a DNA-binding protein. J Biol Chem 2001; 276: 41357-41364
77. Mathis D, Benoist C. Aire. Annu Rev Immunol 2009; 27: 287-312
78. Oven I, BrdičkováN, Kohoutek J, Vaupotič T, Narat M, Peterlin BM. AIRE recruits P-TEFb for transcriptional elongation of target genes in medullary thymic epithelial cells. Mol Cell Biol 2007; 27: 8815-8823
79. Ilmarinen T, Kangas H, Kytömaa T, Eskelin P, Saharinen J, Seeler JS et al. Functional interaction of AIRE with PIAS1 in transcriptional regulation. Mol Immunol 2008; 45: 1847-1862
80. Meloni A, Fiorillo E, Corda D, Incani F, Serra ML, Contini A et al. DAXX I is a new AIRE-interacting protein. J Biol Chem 2010; 285: 13012-13021
81. Org T, Chignola F, Heté nyi C, Gaetani M, Rebane A, Liiv I et al. The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep 2008; 9: 370-376
82. Org T, Rebane A, Kisand K, Laan M, Haljasorg U, Andreson R et al. AIRE activated tissue specific genes have histone modifications associated with inactive chromatin. Hum Mol Genet 2009; 18: 4699-4710
83. Žumer K, Low AK, Jiang H, Saksela K, Peterlin BM. Unmodified histone H3K4 and DNA-dependent protein kinase recruit autoimmune regulator to target genes. Mol Cell Biol 2012; 32: 1354-1362
84. Johnnidis JB, Venanzi ES, Taxman DJ, Ting JP, Benoist CO, Mathis DJ. Chromosomal clustering of genes controlled by the aire transcription factor. Proc Natl Acad Sci USA 2005; 102: 7233-7238
85. Villaseñ or J, Besse W, Benoist C, Mathis D. Ectopic expression of peripheral-tissue antigens in the thymic epithelium: probabilistic, monoallelic, misinitiated. Proc Natl Acad Sci USA 2008; 105: 15854-15859
86. Derbinski J, Pinto S, Rösch S, Hexel K, Kyewski B. Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism. Proc Natl Acad Sci USA 2008; 105: 657-662
87. Rinderle C, Christensen HM, Schweiger S, Lehrach H, Yaspo ML. AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered sub-cellular distribution of mutants lacking the PHD zinc fingers. Hum Mol Genet 1999; 8: 277-290
88. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity 2005; 23: 227-239
89. Hubert FX, Kinkel SA, Davey GM, Phipson B, Mueller SN, Liston A et al. Aire regulates the transfer of antigen from mTECs to dendritic cells for induction of thymic tolerance. Blood 2011; 118: 2462-2472
90. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003; 4: 350-354
91. Aschenbrenner K, D'Cruz LM, Vollmann EH, Hinterberger M, Emmerich J, Swee LK et al. Selection of Foxp31 regulatory T cells specific for self antigen expressed and presented by Aire1 medullary thymic epithelial cells. Nat Immunol 2007; 8: 351-358
92. Hansenne I, Louis C, Martens H, Dorban G, Charlet-Renard C, Peterson P et al. Aire and Foxp3 expression in a particular microenvironment for T cell differentiation. Neuroimmunomodulation 2009; 16: 35-44
93. Malchow S, Leventhal DS, Nishi S, Fischer BI, Shen L, Paner GP et al. Aire-dependent thymic development of tumor-associated regulatory T cells. Science 2013; 339: 1219-1224
94. Devoss JJ, Shum AK, Johannes KP, Lu W, Krawisz AK, Wang P et al. Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1. J Immunol 2008; 181: 4072-4079
95. Gavanescu I, Benoist C, Mathis D. B cells are required for Airedeficient mice to develop multi-organ autoinflammation: a therapeutic approach for APECED patients. Proc Natl Acad Sci USA 2008; 105: 13009-13014
96. Kekalainen E, Miettinen A, Arstila TP. Does the deficiency of Aire in mice really resemble human APECED? Nat Rev Immunol 2007; 7: 1.
97. Jiang W, Anderson MS, Bronson R, Mathis D, Benoist C. Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med 2005; 202: 805-815
98. Jasti S, Warren BD, McGinnis LK, Kinsey WH, Petroff BK, Petroff MG. The autoimmune regulator prevents premature reproductive senescence in female mice. Biol Reprod 2012; 86: 110.
99. Bagavant H, Fusi FM, Baisch J, Kurth B, David CS, Tung KS. Immunogenicity and contraceptive potential of a human zona pellucida 3 peptide vaccine. Biol Reprod 1997; 56: 764-770
100. Cheng M, Fan U, Johannes K, Anderson MS. Antigenic targets in Aire-mediated ovarian autoimmunity. J Immunol 2011; 186 (Meeting Abstract Supplement): 44.41.
101. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 1985; 161: 72-87
102. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. j Exp Med 1996; 184: 387-396
103. SamyET, Parker LA, Sharp CP, Tung KS. Continuous control of autoimmune disease by antigen-dependent polyclonal CD41CD251 regulatory T cells in the regional lymph node. J ExpMed 2005; 202: 771-781
104. Tong ZB, Nelson LM. A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. Endocrinology 1999; 140: 3720-3726
105. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA et al. Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet 2000; 26: 267-268
106. Alimohammadi M, Björklund P, HallgrenA , Pöntynen N, Szinnai G, Shikama N et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.NEngl J Med2008; 358: 1018-1028
107. Hou Y, DeVoss J, Dao V, Kwek S, Simko JP, McNeel DG et al. An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans. J Clin Invest 2009; 119: 2031-2041.